HBM Healthcare Investments NAV falls 1.7% MTD to CHF 297.30 as of Sept. 30

Getlink disclosed 550,000,000 ordinary shares outstanding as of Sept. 30, 2026. Theoretical voting rights totaled 642,851,718. Exercisable voting rights stood at 635,332,063. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Getlink SE published the original content used to generate this news brief via Business Wire (Ref. ID: 202610051200BIZWIRE_USPR_____20261005_BW048564) on October 05, 2026, and is solely responsible for the information contained therein.

Reuters, October 5 – Stifel has raised its year-end target for the S&P 500 .SPX benchmark index from 7,800 to 7,900, citing expectations of stronger corporate earnings and gains driven by AI spending, despite a worsening macroeconomic environment. Key details include: In a report released on Sunday, the brokerage said robust government spending and AI investments are propelling profit growth. However, it also noted that strong economic activity is keeping interest rates elevated for a longer period. The revised target is 1.9% higher than the index’s current level. Despite rising energy costs, persistent inflation, high bond yields, and cooling enthusiasm for AI, U.S. equities remain resilient. The brokerage stated that sticky inflation is once again dominating market movements, strong economic data is putting pressure on stocks, and the safe-haven appeal of bonds has diminished. “Capital expenditures and operating leverage in the tech sector continue to drive margin expansion in the S&P 500,” the report said. Stifel's forecast is slightly below the consensus among brokerages, many of which predict the S&P 500 will close at 8,000 points or higher by the end of 2026 (link), with the bull market extending into next year. (For ease of non-English speakers, Reuters provides automated translations of its reports into several other languages. Since automated translations may contain errors or lack required context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for readers’ convenience. Reuters will not be liable for any damage or loss arising from the use of the automated translation feature.)

11:12 AM EDT, 10/05/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.14% to 1,883.96 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by lender Banco Santander (SAN) and brewing company Anheuser-Busch InBev (BUD), which advanced 3.2% and 0.8% respectively. They were followed by 3D printer company Materialise (MTLS) and internet browser company Opera (OPRA), which were up 0.6% and 0.3% respectively. The decliners from continental Europe were led by biopharmaceutical company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which lost 3.2% each. They were followed by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which decreased 0.9% and 0.4%, respectively. The gainers from the UK were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and software firm Endava plc (DAVA), which climbed 17% and 1.6% respectively. They were followed by medical device maker Smith & Nephew (SNN) and biotech firm Trinity Biotech (TRIB), which increased 1.2% and 1.4% respectively. The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which dropped 3.9% and 1.4% respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and pharmaceutical company GSK (GSK), which fell 1.1% and 1% respectively.